These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19549712)
21. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome. Muntañola A; Mozas P; Mercadal S; Huguet M; Bobillo S; Bastos-Oreiro M; Jiménez-Ubieto A; Rovira J; Rivero A; Tolosa C; Luizaga L; de Villambrosia SG; Novelli S; Caballero D; Salar A; Alonso-Álvarez S; Magnano L; Gutiérrez NC; Sancho JM; López-Guillermo A; Br J Haematol; 2023 Feb; 200(3):306-314. PubMed ID: 36261137 [TBL] [Abstract][Full Text] [Related]
22. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma. Troch M; Wöhrer S; Raderer M Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482 [TBL] [Abstract][Full Text] [Related]
23. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. Mir F; Mattiello F; Grigg A; Herold M; Hiddemann W; Marcus R; Seymour JF; Bolen CR; Knapp A; Nielsen T; Casulo C Am J Hematol; 2020 Dec; 95(12):1503-1510. PubMed ID: 32815559 [TBL] [Abstract][Full Text] [Related]
24. Assessment of prognostic factors in follicular lymphoma patients. Kondo E; Ogura M; Kagami Y; Taji H; Miura K; Takeuchi T; Maeda S; Asakura S; Suzuki R; Nakamura S; Morishima Y Int J Hematol; 2001 Apr; 73(3):363-8. PubMed ID: 11345204 [TBL] [Abstract][Full Text] [Related]
25. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy. Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation. Yang G; Mills M; Kim Y; Figura NB; Doyle C; Oliver D; Grass GD; Robinson T; Chavez J; Kim S Blood Cancer J; 2020 Jan; 9(12):104. PubMed ID: 31894139 [No Abstract] [Full Text] [Related]
27. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Hoster E; Dreyling M; Klapper W; Gisselbrecht C; van Hoof A; Kluin-Nelemans HC; Pfreundschuh M; Reiser M; Metzner B; Einsele H; Peter N; Jung W; Wörmann B; Ludwig WD; Dührsen U; Eimermacher H; Wandt H; Hasford J; Hiddemann W; Unterhalt M; ; Blood; 2008 Jan; 111(2):558-65. PubMed ID: 17962512 [TBL] [Abstract][Full Text] [Related]
28. Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment. Jiménez Londoño GA; García Vicente AM; Poblete García VM; Amo-Salas M; Calle Primo C; Ibañez García Á; Martínez Sanchís B; López-Fidalgo JF; Solano Ramos F; Martínez Hellín A; Díaz Morfa M; Soriano Castrejón Á Rev Esp Med Nucl Imagen Mol; 2016; 35(5):298-305. PubMed ID: 27312693 [TBL] [Abstract][Full Text] [Related]
29. External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse. Boyne DJ; Chua N; Owen C; Joe-Uzuegbu O; Shakir H; Gogna P; Jarada TN; Brenner DR; Elia-Pacitti J; Ewara EM; Cheung WY Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e277-e285. PubMed ID: 37331847 [TBL] [Abstract][Full Text] [Related]
30. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database. Procházka V; Papajík T; Janíková A; Belada D; Kozák T; Šálek D; Sýkorová A; Móciková H; Campr V; Dlouhá J; Langová K; Fürst T; Trněný M Leuk Lymphoma; 2017 Mar; 58(3):601-613. PubMed ID: 27666539 [TBL] [Abstract][Full Text] [Related]
31. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma. Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A Hematol Oncol; 2022 Apr; 40(2):297-301. PubMed ID: 34845733 [TBL] [Abstract][Full Text] [Related]
32. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G; J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481 [TBL] [Abstract][Full Text] [Related]
33. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma. Adams HJ; Nievelstein RA; Kwee TC J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022 [TBL] [Abstract][Full Text] [Related]
34. Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry. Provencio M; Sabín P; Gomez-Codina J; Torrente M; Calvo V; Llanos M; Gumá J; Quero C; Blasco A; Cruz MA; Aguiar D; García-Arroyo F; Lavernia J; Martinez N; Morales M; Saez-Cusi A; Rodriguez D; de la Cruz L; Sanchez JJ; Rueda A; PLoS One; 2017; 12(5):e0177204. PubMed ID: 28493986 [TBL] [Abstract][Full Text] [Related]
35. Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registry. Maartense E; Le Cessie S; Kluin-Nelemans HC; Kluin PM; Snijder S; Wijermans PW; Noordijk EM Ann Oncol; 2002 Aug; 13(8):1275-84. PubMed ID: 12181252 [TBL] [Abstract][Full Text] [Related]
36. Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. Federico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M Haematologica; 2007 Nov; 92(11):1482-8. PubMed ID: 18024396 [TBL] [Abstract][Full Text] [Related]
37. Stage III follicular lymphoma: long-term follow-up and patterns of failure. Ha CS; Kong JS; McLaughlin P; Tucker SL; Fayad LE; Hess MA; Wilder RB; Cabanillas F; Cox JD Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):748-54. PubMed ID: 14529780 [TBL] [Abstract][Full Text] [Related]
38. High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma. Procházka V; Faber E; Raida L; Langová K; Indrák K; Papajík T Leuk Lymphoma; 2012 Jul; 53(7):1306-10. PubMed ID: 22263569 [TBL] [Abstract][Full Text] [Related]
39. [Clinical Significance of Detecting CD4 Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291 [TBL] [Abstract][Full Text] [Related]
40. Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group. Méndez M; Torrente M; Sánchez-Beato M; González-Rincón J; Royuela A; Gómez-Codina J; de la Cruz-Merino L; Rueda A; Llanos M; Quero C; Rodríguez-Abreu D; Gumá J; Monsalvo S; Sabin P; Provencio M Hematol Oncol; 2019 Apr; 37(2):143-150. PubMed ID: 30840776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]